Dialog Box

Ovarian Cancer Australia in the News View all news

Media Releases

Tracey, who was diagnosed with stage 4 ovarian cancer in 2017, is participating in the Workout 4 Women challenge for the third year in a row.

News

Domenica shares her story and low-fibre recipes ideal for postoperative care

News

Niraparib will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 September 2022 for the treatment of women with advanced high-grade ovarian, fallopian tube or primary peritoneal cancer following completion of first-line platinum-based chemother

Media Releases

Expanded use of Olaparib has not yet been recommended for listing on the Pharmaceutical Benefits Scheme

Donate